IP Library › Granted Patent US 10,881,333
Granted Patent B2
US 10,881,333 · App. 15/270,812 · Granted Jan 5, 2021

Method and apparatus for predicting in vivo analyte concentration using learning and a net analyte signal

Inventors: Seonmyeong Choi (Suwon-si, KR); Jinyoung Park (Hwaseong-si, KR)
Assignee: SAMSUNG ELECTRONICS CO., LTD.
A61B5/14532A61B5/1455A61B5/1495A61B5/14546A61B5/7267A61B5/7275G01N33/4833G16H50/20A61B2560/0223G01N21/35G01N2201/129
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,881,333
App. No.
15/270,812
Granted
Jan 5, 2021
Kind
B2
Abstract

A method for predicting a concentration of an in vivo analyte includes obtaining a plurality of in vivo spectra of the in vivo analyte, determining a learning section for a concentration predicting algorithm for the analyte based on an unchanged section, during which the concentration of the analyte is not substantially changed, and a plurality of the in vivo spectra, and predicting the concentration of the in vivo analyte by using the concentration predicting algorithm based on a learned result of the learning section and an intrinsic spectrum of the in vivo analyte.

Claims (57)

1. A method for predicting a concentration of an in vivo analyte, the method comprising:

obtaining a plurality of in vivo spectra of the in vivo analyte;

determining a learning section of a concentration predicting algorithm for the in vivo analyte based on an unchanged section, during which a concentration of the in vivo analyte is not substantially changed, and the in vivo spectra; and

predicting the concentration of the in vivo analyte by using the concentration predicting algorithm based on a learned result of the learning section and an intrinsic spectrum of the in vivo analyte.

2. The method of claim 1 , wherein the in vivo analyte is at least one of glucose, urea, lactate, triglyceride, protein, cholesterol, and ethanol.

3. The method of claim 1 , wherein,

the in vivo analyte is glucose, and

the unchanged section, during which the concentration of the in vivo analyte is not substantially changed, is a fasting section.

4. The method of claim 1 , wherein the in vivo spectrum comprise at least one of an absorption spectrum or a reflection spectrum of an infra-red ray.

5. The method of claim 1 , wherein the in vivo spectrum comprise a dispersion spectrum of a single wavelength electromagnetic wave.

6. The method of claim 1 , wherein the obtaining the in vivo spectra of the in vivo analyte comprises obtaining the in vivo spectra continually at a predetermined time interval.

7. The method of claim 1 , wherein the concentration predicting algorithm comprises a net analyte signal algorithm.

8. The method of claim 1 , wherein the determining the learning section comprises:

calculating a similarity between the in vivo spectra;

determining a section having a high similarity as a similar section; and

determining a section, during which the unchanged section and the similar section overlap each other, as the learning section.

9. The method of claim 8 , wherein the calculating the similarity between the in vivo spectra comprises:

aligning baselines of at least two spectra for calculating similarities thereof among the in vivo spectra; and

calculating a difference between the at least two in vivo spectra, the baselines of which are aligned.

10. The method of claim 1 , wherein the predicting the concentration of the in vivo analyte comprises predicting the concentration of the in vivo analyte in the similar section including the learning section when a length of the learning section is longer than a predetermined section length.

11. The method of claim 1 , wherein the predicting the concentration of the in vivo analyte comprises re-determining the learning section in the similar section when a length of the learning section is shorter than a predetermined length.

12. The method of claim 1 , wherein the predicting the concentration of the in vivo analyte comprises displaying a message to inform a user that a concentration prediction is unavailable when a length of the learning section is shorter than a predetermined length.

13. The method of claim 1 , wherein the in vivo analyte is included in a human body, an animal, a mammal, a non-mammal or a microorganism.

14. An apparatus for predicting a concentration of an in vivo analyte, the apparatus comprising:

a processor; and

a memory,

wherein the processor executes a program stored in the memory to perform:

obtaining a plurality of in vivo spectra of the in vivo analyte;

determining a learning section for predicting the concentration of the in vivo analyte using a net analyte signal based on an unchanged section, and based on the in vivo spectra, wherein the unchanged section is a time duration during which a concentration of the analyte is not substantially changed, and wherein the determining the learning section comprises:

calculating similarities between the in vivo spectra;

determining a section, which has a predetermined similarity, based on the calculated similarities between the in vivo spectra as a similar section; and

determining a section, during which the unchanged section and the similar section overlap each other, as the learning section; and

predicting the concentration of the in vivo analyte by using the net analyte signal and a spectrum changing factor, which factor is not a function of a change in the concentration of the in vivo analyte, during the learning section and by using an intrinsic spectrum of the in vivo analyte, wherein the intrinsic spectrum is a spectrum of the analyte itself obtained from a sample comprised of the analyte dissolved in an aqueous buffer solution.

15. The apparatus of claim 14 , wherein the in vivo analyte is at least one of glucose, urea, lactate, triglyceride, protein, cholesterol, and ethanol.

16. The apparatus of claim 14 , wherein

the in vivo analyte is glucose, and

the unchanged section, during which the concentration of the in vivo analyte is not substantially changed, is a fasting section.

17. The apparatus of claim 14 , wherein each of the in vivo spectra comprises at least one of an absorption spectrum and a reflection spectrum of an infra-red ray.

18. The apparatus of claim 14 , wherein each of the in vivo spectra is obtained by a Raman spectroscopy.

19. The apparatus of claim 14 , wherein when the processor performs the obtaining the in vivo spectra of the in vivo analyte, the processor performs:

obtaining the in vivo spectra repeatedly at a predetermined time interval.

20. The apparatus of claim 14 , wherein, when the processor performs the calculating the similarities between the in vivo spectra, the processor performs:

aligning baselines of at least two in vivo spectra for calculating similarities thereof among the in vivo spectra;

calculating a difference between the at least two in vivo spectra by aligning baselines of the at least two in vivo spectra; and

calculating the similarities between the at least two in vivo spectra based on the difference between the at least two in vivo spectra.

21. The apparatus of claim 14 , wherein, when the processor performs the predicting the concentration of the in vivo analyte, the processor performs:

predicting the concentration of the in vivo analyte in the similar section including the learning section, in a case that a length of the learning section is longer than a predetermined section length.

22. The apparatus of claim 14 , wherein, when the processor performs the predicting the concentration of the in vivo analyte, the processor performs:

re-determining the learning section in the similar section, in a case that a length of the learning section is shorter than a predetermined length.

23. The apparatus of claim 14 , wherein, when the processor performs the predicting the concentration of the in vivo analyte, the processor performs:

displaying a message to inform a user that a concentration prediction is unavailable, when a length of the learning section is shorter than a predetermined length.

24. The apparatus of claim 14 , wherein the in vivo analyte is included in a human body, an animal, a mammal, a non-mammal, or a microorganism.

25. The apparatus of claim 14 further comprising:

a communicator which receives the in vivo spectra from an infra-red sensor or a laser sensor through a wired or wireless network.

26. The apparatus of claim 14 further comprising:

an infra-red sensor which generates the in vivo spectra by radiating an infra-red ray to a human body.

27. The apparatus of claim 14 further comprising: a laser sensor which generates the in vivo spectra by radiating laser light to a human body.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2016
From: CHOI, SEONMYEONG; PARK, JINYOUNG
To: SAMSUNG ELECTRONICS CO., LTD.
Reel/Frame 039804/0508 →
Priority Claims (1)
KR 10-2015-0134872 · Sep 23, 2015 · national
Continuity (1)
Related Publication 20170079565A1 · Mar 23, 2017